Search BioPortfolio:
BioPortfolio
Web
Home
Marketing Services
News
Reports
Company Profiles
InDepth
Drug Discovery
Careers
Conferences
Videos
Search
Contact
Items Ordered:
Cart Value:
New Products:
1.
The Rise of Mid-Sized Pharma
2.
Contract Research Annual Review 2008
3.
Amgen - The Biotech Leader - Market Analyses and Outlook, 2008-2023
4.
The World OTC Pharmaceutical Market Analysis and Forecasts, 2008-2023
5.
Monoclonal Antibodies Report: 2008 Update
6.
Pipeline and Commercial Insight: Neuropathic Pain - UCB's Vimpat set to compete with major players
7.
Stakeholder Opinions: Non-hormonal Treatments for Menopausal Symptoms - Market open to takers as tepid pipeline fails to meet demand
8.
Rx-to-OTC Strategies: Maximizing the Commercial Potential of an Rx-to-OTC Switch
9.
Drug Repositioning Strategies - Serendipity by design
10.
Forecast Insight: Osteoarthritis - The COX-2 pipeline collapses
Best Sellers:
1.
BioNewsCast Press Release Distribution Service
2.
Immunogenicity to Biologics Implications of reactions against biotech drugs
3.
Outsourcing in Drug Discovery, 3rd Edition
4.
American Hospital Register
5.
Professional Designation in Biopharmaceutical Technology - 3 Course Curriculum
6.
Outlook for RNAi, 2007 - siRNA and miRNA in biology, diagnostics and therapeutics
ePharma - The Online Pharmaceutical Industry, 2006-2011
The purpose of this visiongain report is to examine the commercial prospects of online technologies in the pharmaceutical sector. In particular, this report examines the fast-growing fields of pharmaceutical eMarketing, eDetailing, ePrescribing and online drug sales. Online technological solutions have great potential to benefit - even revolutionise the marketing efforts of drug companies. Visiongain predicts that all aspects of pharmaceutical eMarketing will exhibit steady growth from 2006-2011. Key technological solutions - such as Internet-enabled DTC promotion, eDetailing and ePrescribing - will drive that expansion. Sales of prescription drugs via the Internet will also be significant.
ePharma: The Online Pharmaceutical Industry, 2006-2011 examines this burgeoning new method of marketing and the selling of drugs online through comprehensive primary and secondary research. In addition to consultation with experts in eMarketing and ePrescribing, the research involved a detailed study of policy documents, industrial reports and relevant news. Importantly, Visiongain also applied techniques such as financial forecasting, SWOT analyses and qualitative projections. The result is a comprehensive market-based report with detailed analysis and informed opinion.
In particular, this report concentrates on the following essential aspects of online solutions in the pharmaceutical sector:
> Technologies that drive the online pharmaceutical sector
> Key players in eMarketing and ePrescribing both providers of technology and leading users of these solutions or platforms
> Forecasts of key metrics in eMarketing, ePrescribing and online drug sales from 2006-2011
> Drivers and opportunities in pharmaceutical eMarketing, both to consumers and medical professionals
> Restraints and threats in pharmaceutical eMarketing
> Regulatory issues in pharmaceutical eMarketing, ePrescribing and online drug sales
> Comprehensive assessments of relevant business models, technological solutions and associated issues
Why you should buy this report:
> To receive a comprehensive analysis of the prospects for online solutions in pharmaceutical sales, marketing and prescribing from 2006-2011
> To discover predicted investments, growth rates and other key metrics for online pharmaceutical solutions from 2006-2011
> To determine the forces that influence pharmaceutical eMarketing, ePrescribing and online drug sales: - > Competitive characteristics of the marketRegulatory, technological and societal issues - Drivers and restraints - > Strengths, weaknesses, opportunities and threats
> To find out where pharmaceutical eMarketing, ePrescribing and online drug sales are heading - both technologically and commercially
Lead Analyst: Dr Gordon Low Publication Date: 28/07/06 Pages: 171
Single user licence: The Report is delivered via an on-line reading room. One use access only, the report is in Flash format in a printable format.
Department: Report is delivered via an on line reading room. Five user access only, the report is in Flash format in a printable format.
Company/site wide licence: The report is delivered in email format as a PDF document with no locking system attached. The report can be loaded onto the company's intranet site.
Table of Contents
Price
Single User Licence $2998.00
Department Licence 5 Users $5998.00
Company-wide Intranet Licence $9998.00
Buy Biotechnology Management Reports online with BioPortfolio's secure E-Commerce portal.